These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 28722500

  • 1. Post-marketing surveillance study of the long-term use of mizoribine for the treatment of lupus nephritis: 2-Year results.
    Takeuchi T, Okada K, Yoshida H, Yagi N.
    Mod Rheumatol; 2018 Jan; 28(1):85-94. PubMed ID: 28722500
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis.
    Nomura A, Shimizu H, Kishimoto M, Suyama Y, Rokutanda R, Ohara Y, Yamaguchi K, Okada M.
    Lupus; 2012 Nov; 21(13):1444-9. PubMed ID: 22917589
    [Abstract] [Full Text] [Related]

  • 3. The first year results of mizoribine/tacrolimus-based multitarget treatment for consecutive patients with lupus nephritis.
    Kagawa H, Hiromasa T, Yamanaka R, Hayashi R, Tsunashima Y, Inoue T, Sada KE.
    Clin Exp Nephrol; 2018 Dec; 22(6):1371-1378. PubMed ID: 29948442
    [Abstract] [Full Text] [Related]

  • 4. Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
    Kagawa H, Hiromasa T, Hara T, Takaki A, Yamanaka R, Sada KE, Makino H.
    Clin Exp Nephrol; 2012 Oct; 16(5):760-6. PubMed ID: 22492013
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis.
    Tanaka H, Aizawa T, Watanabe S, Oki E, Tsuruga K, Imaizumi T.
    Lupus; 2014 Jul; 23(8):813-8. PubMed ID: 24651669
    [Abstract] [Full Text] [Related]

  • 6. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H.
    Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
    [Abstract] [Full Text] [Related]

  • 7. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H, Tsugawa K, Suzuki K, Nakahata T, Ito E.
    Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
    [Abstract] [Full Text] [Related]

  • 8. Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study.
    Fei Y, Wu Q, Zhang W, Chen H, Hou Y, Xu D, Li M, Zhang X, Zhao Y, Zeng X, Zhang F.
    Clin Exp Rheumatol; 2013 Jul; 31(1):62-8. PubMed ID: 22935463
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
    Ikeuchi H, Hiromura K, Takahashi S, Mishima K, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Kuroiwa T, Nojima Y.
    Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis.
    Nishi E, Kameda H, Ogawa H, Nagasawa H, Takei H, Okuyama A, Kurasawa T, Kondo T, Nishimura K, Shirai Y, Sakai R, Ito T, Takeuchi T, Amano K.
    Mod Rheumatol; 2013 Jan; 23(1):97-103. PubMed ID: 22526831
    [Abstract] [Full Text] [Related]

  • 11. Long-Term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis in Japan: 10-Year Analysis of the Real-World TRUST Study.
    Takeuchi T, Wakasugi N, Hashida T, Uno S, Makino H.
    J Rheumatol; 2024 Jun 01; 51(6):613-621. PubMed ID: 38359944
    [Abstract] [Full Text] [Related]

  • 12. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V.
    Lupus; 2018 Apr 01; 27(4):647-656. PubMed ID: 29105558
    [Abstract] [Full Text] [Related]

  • 13. Long-term effects of tacrolimus for maintenance therapy of lupus nephritis: a 5-year retrospective study at a single center.
    Karasawa K, Uchida K, Kodama M, Moriyama T, Nitta K.
    Rheumatol Int; 2018 Dec 01; 38(12):2271-2277. PubMed ID: 30203113
    [Abstract] [Full Text] [Related]

  • 14. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
    Tanaka H, Watanabe S, Aizawa-Yashiro T, Oki E, Kumagai N, Tsuruga K, Ito E.
    Nephron Clin Pract; 2012 Dec 01; 121(3-4):c165-73. PubMed ID: 23327881
    [Abstract] [Full Text] [Related]

  • 15. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB, Won S, Bae SC.
    Lupus; 2018 May 01; 27(6):1007-1011. PubMed ID: 29448881
    [Abstract] [Full Text] [Related]

  • 16. Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
    Kurasawa T, Nagasawa H, Nishi E, Takei H, Okuyama A, Kondo T, Nishimura K, Sakai R, Shibata A, Chino K, Ogawa H, Ito T, Amano K, Kato H.
    Intern Med; 2013 May 01; 52(10):1125-30. PubMed ID: 23676603
    [Abstract] [Full Text] [Related]

  • 17. Tacrolimus use and renal function in pregnancy with lupus nephritis: Analysis of post-marketing surveillance data in Japan.
    Suzuki K, Uno S, Wakasugi N.
    Mod Rheumatol; 2023 Aug 25; 33(5):944-952. PubMed ID: 35982545
    [Abstract] [Full Text] [Related]

  • 18. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
    Feng X, Gu F, Chen W, Liu Y, Wei H, Liu L, Yin S, Da Z, Sun L.
    Chin Med J (Engl); 2014 Aug 25; 127(21):3718-23. PubMed ID: 25382325
    [Abstract] [Full Text] [Related]

  • 19. Study of the efficacy of mizoribine in lupus nephritis in Chinese patients.
    Zhang M, Xing CY, Liu J.
    Rheumatol Int; 2013 Nov 25; 33(11):2737-42. PubMed ID: 23797779
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study.
    Mok CC, Tong KH, To CH, Siu YP, Au TC.
    Kidney Int; 2005 Aug 25; 68(2):813-7. PubMed ID: 16014060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.